# Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Topics in Aging, Neurological, Mental and Behavioral Health.
*Date:* May 5-6, 2026.
*Time:* 9:30 a.m. to 5:30 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Varsha Shukla, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 594-2407, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Clinical Trials: Cardiovascular and Respiratory Topics.
*Date:* May 5, 2026.
*Time:* 10:00 a.m. to 5:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Rupali Das, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0023, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Cancer Genetics, Gene Regulation and Oncogenesis.
*Date:* May 5, 2026.
*Time:* 11:00 a.m. to 6:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Wing-hang Tong, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (302) 402-0360, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Fellowships: Genes, Genomes and Genetics.
*Date:* May 5, 2026.
*Time:* 12:00 p.m. to 5:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Lisa A. Dunbar, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Pathogenic Eukaryotes.
*Date:* May 5, 2026.
*Time:* 12:00 p.m. to 4:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Frank S. De Silva, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Fellowships: Clinical Care, Disease Management and Health Outcomes.
*Date:* May 6-7, 2026.
*Time:* 9:30 a.m. to 6:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Karen Nieves Lugo, Ph.D., MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-1366, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; PAR-23-145: Maximizing Investigators' Research Award.
*Date:* May 6, 2026.
*Time:* 10:00 a.m. to 7:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Laureen Elizabeth Connell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Room 710K, Bethesda, MD 20892, (301) 480-3629, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; NIH Support for Conferences and Scientific Meetings.
*Date:* May 6, 2026.
*Time:* 10:00 a.m. to 6:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Trinh T. Tran, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-5843, *[email protected]* .
*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Radiation Therapy, Radiopharmaceuticals, and Radiobiology Review.
*Date:* May 6, 2026.
*Time:* 10:00 a.m. to 6:00 p.m.
*Agenda:* To review and evaluate grant applications.
*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
*Meeting Format:* Virtual Meeting.
*Contact Person:* Susan Lynn Spence, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, *[email protected]* .
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: April 6, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.